Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dina Robaa

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
Chemistry & Biodiversity|March 16, 2011
A novel non-phenolic dibenzazecine derivative with nanomolar affinities for dopamine receptorsDina Robaa, Shams Eldin AbulAzm, Jochen Lehmann, et al.
Archiv Der Pharmazie|March 14, 2026
AI-Based Prediction of PROTAC- and Molecular Glue-Mediated Ternary Complexes: A Comparative Evaluation of AlphaFold 3 and Boltz-2Lino Riepenhausen, Anne-Christin Sarnow, Dina Robaa, et al.
Medicinal Research Reviews|January 18, 2017
The Current State of NAD<sup>+</sup> -Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic TargetsMatthias Schiedel, Dina Robaa, Tobias Rumpf, et al.
Future Medicinal Chemistry|July 4, 2018
Design of selective histone deacetylase inhibitors: rethinking classical pharmacophoreJelena Melesina, Lucas Praetorius, Conrad V Simoben, et al.
Journal of Medicinal Chemistry|December 25, 2015
KATching-Up on Small Molecule Modulators of Lysine AcetyltransferasesRoman P Simon, Dina Robaa, Zayan Alhalabi, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2022
Histone Deacetylase (HDAC) Inhibitors for the Treatment of SchistosomiasisEhab Ghazy, Mohamed Abdelsalam, Dina Robaa, et al.
Frontiers in Pharmacology|June 6, 2018
Pharmacogenetic Aspects of the Interaction of AT1 Receptor Antagonists With ATP-Binding Cassette Transporter <i>ABCG2</i>Anne Ripperger, Anna Krischer, Dina Robaa, et al.
The Journal of Biological Chemistry|May 22, 2024
Fatty acid binding to the human transport proteins FABP3, FABP4, and FABP5 from a Ligand's perspectiveSebastian Michler, Florian Arndt Schöffmann, Dina Robaa, et al.
Journal of Molecular Graphics & Modelling|November 24, 2015
Homology modeling of parasite histone deacetylases to guide the structure-based design of selective inhibitorsJelena Melesina, Dina Robaa, Raymond J Pierce, et al.
Bioorganic & Medicinal Chemistry Letters|November 5, 2015
Benzo[7]annulene-based GluN2B selective NMDA receptor antagonists: Surprising effect of a nitro group in 2-positionSandeep Gawaskar, Dirk Schepmann, Alessandro Bonifazi, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Chemistry & Biodiversity|March 16, 2011
A novel non-phenolic dibenzazecine derivative with nanomolar affinities for dopamine receptorsDina Robaa, Shams Eldin AbulAzm, Jochen Lehmann, et al.
Archiv Der Pharmazie|March 14, 2026
AI-Based Prediction of PROTAC- and Molecular Glue-Mediated Ternary Complexes: A Comparative Evaluation of AlphaFold 3 and Boltz-2Lino Riepenhausen, Anne-Christin Sarnow, Dina Robaa, et al.
Medicinal Research Reviews|January 18, 2017
The Current State of NAD<sup>+</sup> -Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic TargetsMatthias Schiedel, Dina Robaa, Tobias Rumpf, et al.
Future Medicinal Chemistry|July 4, 2018
Design of selective histone deacetylase inhibitors: rethinking classical pharmacophoreJelena Melesina, Lucas Praetorius, Conrad V Simoben, et al.
Journal of Medicinal Chemistry|December 25, 2015
KATching-Up on Small Molecule Modulators of Lysine AcetyltransferasesRoman P Simon, Dina Robaa, Zayan Alhalabi, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2022
Histone Deacetylase (HDAC) Inhibitors for the Treatment of SchistosomiasisEhab Ghazy, Mohamed Abdelsalam, Dina Robaa, et al.
Frontiers in Pharmacology|June 6, 2018
Pharmacogenetic Aspects of the Interaction of AT1 Receptor Antagonists With ATP-Binding Cassette Transporter <i>ABCG2</i>Anne Ripperger, Anna Krischer, Dina Robaa, et al.
The Journal of Biological Chemistry|May 22, 2024
Fatty acid binding to the human transport proteins FABP3, FABP4, and FABP5 from a Ligand's perspectiveSebastian Michler, Florian Arndt Schöffmann, Dina Robaa, et al.
Journal of Molecular Graphics & Modelling|November 24, 2015
Homology modeling of parasite histone deacetylases to guide the structure-based design of selective inhibitorsJelena Melesina, Dina Robaa, Raymond J Pierce, et al.
Bioorganic & Medicinal Chemistry Letters|November 5, 2015
Benzo[7]annulene-based GluN2B selective NMDA receptor antagonists: Surprising effect of a nitro group in 2-positionSandeep Gawaskar, Dirk Schepmann, Alessandro Bonifazi, et al.
Pageof 8